UDP-glucuronosyltransferases and clinical drug-drug interactions

TKL Kiang, MHH Ensom, TKH Chang - Pharmacology & therapeutics, 2005 - Elsevier
… by the drugs investigated to date. In general, UGT-mediated human drug interaction studies
are … The factors that complicate the interpretation of this type of drug interaction data are …

[HTML][HTML] Pharmacokinetic drug-drug interaction and their implication in clinical management

C Palleria, A Di Paolo, C Giofrè, C Caglioti… - Journal of research in …, 2013 - ncbi.nlm.nih.gov
Drug-drug interactions (DDIs) are one of the commonest … of clinically relevant drug interactions,
which can induce the development of ADRs, and both reduce,[8,9] or increase the clinical

Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical DrugDrug Interactions

E Russo, F Scicchitano, BJ Whalley… - Phytotherapy …, 2014 - Wiley Online Library
… of HP–drug interactions. Here, we analyse the existing evidence describing the clinical
consequence of HP–drug interactions. Although some of the reported interactions are based on …

Clinically relevant drug-drug interactions in primary care

M Carpenter, H Berry, AL Pelletier - American family physician, 2019 - aafp.org
drug metabolizing isoenzymes is the most common mechanism by which clinically important
drug interactions … with a clinical pharmacist when clinical circumstances require the use of …

Clinical relevance of drug-drug interactions: a structured assessment procedure

EN van Roon, S Flikweert, M le Comte, PNJ Langendijk… - Drug safety, 2005 - Springer
… The procedure for assessment of the clinical relevance of drug interactions as … of the clinical
relevance of potential interacting drug combinations. A CIS selectively generating interaction

[HTML][HTML] Clinically significant drug interactions

PW Ament, JG Bertolino, JL Liszewski - American family physician, 2000 - aafp.org
… Multiple drug regimens carry the risk of adverse interactions. Precipitant drugs modify the
object drug'sinteraction may be clinically significant at even lower dosages of the pain reliever. …

… of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interaction

OA Fahmi, S Hurst, D Plowchalk, J Cook, F Guo… - Drug Metabolism and …, 2009 - ASPET
drug metabolism and because it is the most frequent target for pharmacokinetic drug-drug
interactions (… In this study, the prediction of clinical DDIs for 30 drugs on the pharmacokinetics …

Application of CYP3A4 in vitro data to predict clinical drugdrug interactions; predictions of compounds as objects of interaction

KA Youdim, A Zayed, M Dickins… - … journal of clinical …, 2008 - Wiley Online Library
clinical ketoconazole drug interaction studies with substrates of CYP3A4. Using SIMCYP®
the magnitude of ketoconazole interactions … of the clinical DDI and to optimize the procedure. …

The impact of in vitro binding on in vitro-in vivo extrapolations, projections of metabolic clearance and clinical drug-drug interactions

K Grime, RJ Riley - Current drug metabolism, 2006 - ingentaconnect.com
drugs failed in development because of poor pharmacokinetics (PK) [1]. The major contribution
of metabolic instability and drug-drug interaction (DDI) potential have resulted in drug

Important drug-drug interactions in the elderly

RM Seymour, PA Routledge - Drugs & aging, 1998 - Springer
drug interactions in everyday clinical practice. For the purposes of this article, an adverse
drugdrug interaction is defined as either the enhancement or reduction of action of one drug by …